We just received data on a new analyst forecast for $RYTM. Corinne Jenkins from Goldman Sachs set a price target of 139.0 for RYTM.
To track analyst ratings and price targets for $RYTM, check out Quiver Quantitative's $RYTM forecast page.
$RYTM Price Targets
Multiple analysts have issued price targets for $RYTM recently. We have seen 12 analysts offer price targets for $RYTM in the last 6 months, with a median target of $110.0.
Here are some recent targets:
- Corinne Jenkins from Goldman Sachs set a target price of $139.0 on 10/17/2025
- Jeffrey Hung from Morgan Stanley set a target price of $129.0 on 10/16/2025
- Raghuram Selvaraju from HC Wainwright & Co. set a target price of $110.0 on 09/29/2025
- Jonathan Wolleben from JMP Securities set a target price of $142.0 on 09/25/2025
- Seamus Fernandez from Guggenheim set a target price of $120.0 on 08/06/2025
- Whitney Ijem from Canaccord Genuity set a target price of $105.0 on 07/18/2025
- Derek Archila from Wells Fargo set a target price of $129.0 on 07/10/2025
$RYTM Insider Trading Activity
$RYTM insiders have traded $RYTM stock on the open market 27 times in the past 6 months. Of those trades, 0 have been purchases and 27 have been sales.
Here’s a breakdown of recent trading of $RYTM stock by insiders over the last 6 months:
- HUNTER C SMITH (Chief Financial Officer) has made 0 purchases and 5 sales selling 70,208 shares for an estimated $6,094,379.
- DAVID W J MCGIRR has made 0 purchases and 2 sales selling 65,431 shares for an estimated $4,267,494.
- JOSEPH SHULMAN (Chief Technical Officer) has made 0 purchases and 5 sales selling 32,922 shares for an estimated $3,164,838.
- DAVID P MEEKER (President and CEO) has made 0 purchases and 2 sales selling 43,620 shares for an estimated $2,837,333.
- PAMELA J. CRAMER (Chief Human Resources Officer) has made 0 purchases and 6 sales selling 31,154 shares for an estimated $2,267,774.
- CHRISTOPHER PAUL GERMAN (Corporate Controller & CAO) has made 0 purchases and 4 sales selling 7,386 shares for an estimated $589,733.
- YANN MAZABRAUD (EVP, Head of International) sold 6,745 shares for an estimated $438,946
- ALASTAIR GARFIELD (Chief Scientific Officer) has made 0 purchases and 2 sales selling 1,319 shares for an estimated $85,483.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RYTM Hedge Fund Activity
We have seen 121 institutional investors add shares of $RYTM stock to their portfolio, and 111 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRIMECAP MANAGEMENT CO/CA/ removed 909,285 shares (-15.7%) from their portfolio in Q2 2025, for an estimated $57,457,719
- POLAR CAPITAL HOLDINGS PLC added 750,870 shares (+150.2%) to their portfolio in Q2 2025, for an estimated $47,447,475
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 678,760 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $42,890,844
- JPMORGAN CHASE & CO added 639,919 shares (+445.5%) to their portfolio in Q2 2025, for an estimated $40,436,481
- BLACKROCK, INC. removed 587,217 shares (-8.6%) from their portfolio in Q2 2025, for an estimated $37,106,242
- RA CAPITAL MANAGEMENT, L.P. removed 523,053 shares (-8.6%) from their portfolio in Q2 2025, for an estimated $33,051,719
- WOODLINE PARTNERS LP added 514,381 shares (+inf%) to their portfolio in Q2 2025, for an estimated $32,503,735
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
